re 102 has been researched along with Thrombocythemia, Essential in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Atsuta, Y; Doki, N; Fukuda, T; Ichinohe, T; Ishikawa, J; Kanda, Y; Kiyoi, H; Minami, Y; Mori, T; Murata, M; Nagamura-Inoue, T; Nishida, T; Shimazu, Y; Shirane, S; Suzuki, R; Tanaka, M; Togitani, K; Uchida, N | 1 |
1 other study(ies) available for re 102 and Thrombocythemia, Essential
Article | Year |
---|---|
Allogeneic Hematopoietic Stem Cell Transplantation for Post-essential Thrombocythemia and Post-polycythemia Vera Myelofibrosis.
Topics: Adult; Aged; Erythrocyte Transfusion; Female; Fetal Blood; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Japan; Male; Middle Aged; Morpholines; Platelet Transfusion; Polycythemia Vera; Primary Myelofibrosis; Prognosis; Retrospective Studies; Survival Rate; Thrombocythemia, Essential; Tissue Donors; Transplantation, Homologous; Treatment Outcome | 2020 |